The Alzheimer’s Association is accepting nominations for two "Best Paper" awards in Neuroimaging. To be considered, submit your paper by May 4, 2009.
Prizes
Both awards carry unrestricted prizes.
- Alzheimer's Disease Neuroimaging Award
An unrestricted prize of $5,000 in recognition of the "best paper" published in any peer-reviewed journal between July 1, 2008 and June 30, 2009. - New Investigator Alzheimer's Disease Neuroimaging Award
An unrestricted prize of $1,000 awarded to the "best paper" most recently published by a promising new investigator between July 1, 2008 and June 30, 2009.
Selection criteria
- The topic of the papers must relate to in-vivo neuroimaging of a neurodegenerative process.
- The nomination for the $5,000 award must be for papers published or in-press galley proof in the period between July 1, 2008 and June 30, 2009.
- The nomination for the $1,000 award will be for a recently published paper or in-press galley proof by an investigator new to the Alzheimer's disease field. This will be determined based on an accompanying one-page letter by the candidate and a CV listing all publications and all grant support. In general, junior faculty with limited support for Alzheimer's disease research and limited publications in the Alzheimer's field will be considered.
- Selection of the awardees will be made by the Awards Jury convened by the Alzheimer's Association.
How to apply
Send all nomination information to neuroaward@alz.org. All materials must be received by May 4, 2009.
- The Alzheimer’s Disease Neuroimaging Award - Submit paper along with candidate’s name and contact information.
- The New Investigator’s Alzheimer’s Disease Neuroimaging Award -Submit paper, letter and curriculum vita.
Only full manuscripts or those in final galley format from peer reviewed journals will be accepted for consideration. Nominees may be asked to supply additional information to the committee.
Award jury
The Award Jury consists of active senior investigators from the fields of neuroimaging and Alzheimer research, including experts in specific imaging modalities as well as anatomy, physiology, biochemistry and molecular biology. This year’s jury is chaired by Mony de Leon and co-chaired by Zaven Khachaturian. The identity of the panel of judges will remain anonymous until the winners are selected.
Administration of awards
The award presentations and the disposition of all future funds donated for these prizes are administered by the Alzheimer's Association. An Award Founders Group, consisting of an executive committee and the original group of donors, assist the Association in ensuring the perpetuity of the award. The current Founders Group is comprised of:
Executive Committee
*Mony de Leon, Chair
New York University, New York, N.Y., United States
Zaven Khachaturian, Co-chair
Kachaturian and Associates, Inc., Potomac, Md., United States
Samuel E. Gandy, Co-chair
Mt. Sinai School of Medicine, Annenberg, N.Y., United States
Founding Donors
Heike Braak
JW Goethe University, Frankfurt, Germany
Mony de Leon*
New York University, New York, N.Y., United States
Khalid Iqbal
Institute for Basic Research in Developmental Disabilities, Staten Island, N.Y., United States
William Jagust
University of California, Berkeley, Berkeley, Calif., United States
Judes Poirier
McGill University, Centre for Studies in Aging, Verdun, Que., Canada
Barry Reisberg
New York University Medical Center, New York, N.Y., United States
Philip Scheltens
VU Medical Center, Amsterdam, the Netherlands
Peter J. Snyder
Pfizer Global Research & Development, Groton, Conn., United States
Jerzy Wegiel
Institute for Basic Research in Developmental Disabilities, Staten Island, N.Y., United States
Thomas Wisniewski
New York University School of Medicine, New York, N.Y., United States
*Organizer
Contact information
For additional information, please contact: neuroimaging@alz.org.
